Clinical trial
Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel
NCT00111943 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- October 31, 2007
- Enrollment
- 200 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.